| pubmed-article:19657304 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19657304 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:19657304 | lifeskim:mentions | umls-concept:C0019004 | lld:lifeskim |
| pubmed-article:19657304 | lifeskim:mentions | umls-concept:C1524112 | lld:lifeskim |
| pubmed-article:19657304 | lifeskim:mentions | umls-concept:C0020503 | lld:lifeskim |
| pubmed-article:19657304 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:19657304 | lifeskim:mentions | umls-concept:C0034606 | lld:lifeskim |
| pubmed-article:19657304 | lifeskim:mentions | umls-concept:C1516048 | lld:lifeskim |
| pubmed-article:19657304 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:19657304 | pubmed:dateCreated | 2010-10-13 | lld:pubmed |
| pubmed-article:19657304 | pubmed:abstractText | To evaluate the effect of calcimimetics with 99mTc-methoxy-isobutyl-isonitrile (MIBI) parathyroid scintigraphy in secondary hyperparathyroidism. | lld:pubmed |
| pubmed-article:19657304 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19657304 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19657304 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19657304 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19657304 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19657304 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19657304 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19657304 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19657304 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:19657304 | pubmed:issn | 1473-5628 | lld:pubmed |
| pubmed-article:19657304 | pubmed:author | pubmed-author:PonsFrancesca... | lld:pubmed |
| pubmed-article:19657304 | pubmed:author | pubmed-author:FusterDavidD | lld:pubmed |
| pubmed-article:19657304 | pubmed:author | pubmed-author:MuxíAfricaA | lld:pubmed |
| pubmed-article:19657304 | pubmed:author | pubmed-author:MartínGloriaG | lld:pubmed |
| pubmed-article:19657304 | pubmed:author | pubmed-author:SetoainXavier... | lld:pubmed |
| pubmed-article:19657304 | pubmed:author | pubmed-author:TorregrosaJos... | lld:pubmed |
| pubmed-article:19657304 | pubmed:author | pubmed-author:DomenechBeatr... | lld:pubmed |
| pubmed-article:19657304 | pubmed:author | pubmed-author:CasellasJoanJ | lld:pubmed |
| pubmed-article:19657304 | pubmed:author | pubmed-author:SolàOriolO | lld:pubmed |
| pubmed-article:19657304 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19657304 | pubmed:volume | 30 | lld:pubmed |
| pubmed-article:19657304 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19657304 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19657304 | pubmed:pagination | 890-4 | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:meshHeading | pubmed-meshheading:19657304... | lld:pubmed |
| pubmed-article:19657304 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19657304 | pubmed:articleTitle | Dual-phase 99mTc-MIBI scintigraphy to assess calcimimetic effect in patients on haemodialysis with secondary hyperparathyroidism. | lld:pubmed |
| pubmed-article:19657304 | pubmed:affiliation | Nuclear Medicine Department, Hospital Clínic, Barcelona, Spain. dfuster@clinic.ub.es | lld:pubmed |
| pubmed-article:19657304 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:19657304 | pubmed:publicationType | Clinical Trial | lld:pubmed |
